Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DOJ
FDA Warns Cipher Over “Misleading” Marketing Materials
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a warning letter to Cipher…
Celgene Settles Whistleblower Suit for $280 Million
Late July 2017, Celgene Corp., a manufacturer of pharmaceuticals, agreed to pay $280 million to settle fraud allegations related…
DOJ Announces Another FCA Settlement – Sightpath Medical and TLC…
In late August 2017, the United States Department of Justice (DOJ) announced a $12 million settlement with Sightpath Medical and…
Celgene Settles Cancer Drug Whistleblower Suit
Celgene Corporation has settled a whistleblower lawsuit for $280 million, alleging that the pharmaceutical company committed fraud…
Largest Fraud Takedown Announced by AG Sessions
On Thursday, July 13, 2017, United States Attorney General Jeff Sessions and Department of Health and Human Services (HHS)…
Effectiveness, The Holy Grail of Compliance – Both the DOJ & OIG…
Measuring the effectiveness of compliance programs is no easy task since governing agencies have not published a template that…
An FCA Journey – Allergan to Pay $53M to DOJ
Allergan has been hit with hefty fines over the past several months. This article outlines Allergan's alleged wrongdoing, and the…
Quest to Pay $6 Million to Settle Kickback and Unnecessary Testing…
On April 28, 2017, the United States Department of Justice announced a settlement with Quest Diagnostics, Inc., for $6 million to…
Novo Nordisk Settles Qui Tam Suit
Novo Nordisk is in the midst of settling a whistleblower lawsuit that alleges that the company ran a “white-coat marketing scheme”…
Mylan Settlement Classified as “Too Low”
Many of our readers may remember back in October 2016, when Mylan agreed to pay $465 million to settle claims related to the way…